Most senior healthcare executives agreed that a healthcare system that embraces transparency will produce safer care and better outcomes, but a minority are happy with the current degree of transparency in their organization.
Most senior healthcare executives (93%) agreed that a healthcare system that embraces transparency will produce safer care and better outcomes, according to the poll results of the National Patient Safety Foundation’s (NPSF) annual Patient Safety Congress. However, only 22% said they were satisfied with the degree of transparency in their organization.
According to the NPSF, making transparency part of routine practice starts with focusing on the relationship between clinicians and patients, and it has developed a series of best practice approaches and educational opportunities specific to Communication and Resolution Programs.
“Transparency is essential if professionals and organizations are to learn from mistakes and implement practices to keep them from recurring,” note Tejal K. Gandhi, MD, MPH, CPPS, and Patricia McTiernan, MS, of the NPSF, writing in “A Necessary Step to Safer Care,” published online in Inside Medical Liability.
The domains where transparency must become part of routine practice include:
NPSF acknowledges there are barriers that prevent greater openness, such as the fear of litigation and concerns about damage to a provider’s or organization’s reputation when something goes wrong. However, the report points out that these fears are unfounded, according to organizations that have pursued greater transparency.
“While clinical care is an important focus for expanding openness, it is only one area of healthcare where greater transparency is needed,” the authors concluded. “If we really want to lead through learning, we must move toward greater transparency among clinicians through peer review or other mechanisms; among organizations through regional or national collaboratives; and with the public, through reporting of useful quality and safety metrics.”
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Pegcetacoplan for PNH More Cost-Effective Than Anti-C5 Monoclonal Antibodies
April 18th 2024A cost-utility analysis conducted from the perspective of the Italian health system found that pegcetacoplan was more effective and less costly than 2 complement 5 (C5) inhibitors for the treatment of paroxysmal nocturnal hemoglobinuria (PNH).
Read More
Many Patients With Psoriasis in Clinical Trials Experience Nocebo Effects, Study Finds
April 18th 2024Half of patients exposed to placebo in clinical trials experienced adverse events (AEs), which may be partially explainable by nocebo effects, according to a recent review and meta-analysis.
Read More
Low-Volume Hospitals Had Higher Reoperation Rate, Postoperative Complications in CRC
April 18th 2024Patients opting for elective colorectal surgery to address colorectal cancer (CRC) could have different rates of reoperation and postoperative complications based on the size of the hospital.
Read More